Literature DB >> 8027996

Direct and indirect effects of mutations in lambda PRM on open complex formation at the divergent PR promoter.

R S Fong1, S Woody, G N Gussin.   

Abstract

A detailed kinetic analysis demonstrates that, in vitro, mutations in the PRM promoter of bacteriophage lambda can increase the rate of open complex formation at the divergent, lytic promoter PR in either of two ways. (1) PRM- mutations, typified by PRMKM11, indirectly stimulate PR by eliminating interference from RNA polymerase (RNAP) molecules bound at wild-type PRM. This effect can be observed only when PR is itself mutated because open complexes normally form so rapidly at wild-type PR that they are unaffected by PRM. It has been shown previously that PR and PRM can be occupied simultaneously by RNAP, suggesting that interference from PRM is mediated at a step subsequent to binding of RNAP to PR. This conclusion is supported by kinetic data, which indicate that inactivating PRM affects PRx3 by increasing kf, the rate of isomerization of closed to open complexes, four- to fivefold. (2) In addition to its indirect effect, the mutation PRM116, which is located at -33 with respect to PRM and -50 with respect to PR, directly increases the intrinsic strength of PR. PRM116 increases from 11 to 12 the number of A:T or T:A base-pairs in a 12 bp AT-rich sequence located between 47 and 58 bp upstream from PR; we suggest that this upstream sequence contributes directly to PR promoter strength. We also show that the PRx3 mutation causes a 100-fold decrease in kf. This result indicates that the -35 consensus region plays a major role in the isomerization of closed to open complexes at PR.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8027996     DOI: 10.1006/jmbi.1994.1426

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  8 in total

1.  Promoter interference in a bacteriophage lambda control region: effects of a range of interpromoter distances.

Authors:  M G Strainic; J J Sullivan; J Collado-Vides; P L deHaseth
Journal:  J Bacteriol       Date:  2000-01       Impact factor: 3.490

2.  Why the lysogenic state of phage lambda is so stable: a mathematical modeling approach.

Authors:  Moisés Santillán; Michael C Mackey
Journal:  Biophys J       Date:  2004-01       Impact factor: 4.033

3.  Sequence tolerance of the phage lambda PRM promoter: implications for evolution of gene regulatory circuitry.

Authors:  Christine B Michalowski; Megan D Short; John W Little
Journal:  J Bacteriol       Date:  2004-12       Impact factor: 3.490

4.  Evidence that the promoter can influence assembly of antitermination complexes at downstream RNA sites.

Authors:  Ying Zhou; Ting Shi; Mark A Mozola; Eric R Olson; Karla Henthorn; Susan Brown; Gary N Gussin; David I Friedman
Journal:  J Bacteriol       Date:  2006-03       Impact factor: 3.490

5.  Upstream interactions at the lambda pRM promoter are sequence nonspecific and activate the promoter to a lesser extent than an introduced UP element of an rRNA promoter.

Authors:  Y Tang; K Murakami; A Ishihama; P L deHaseth
Journal:  J Bacteriol       Date:  1996-12       Impact factor: 3.490

6.  New Insights into the Phage Genetic Switch: Effects of Bacteriophage Lambda Operator Mutations on DNA Looping and Regulation of PR, PL, and PRM.

Authors:  Dale E A Lewis; Gary N Gussin; Sankar Adhya
Journal:  J Mol Biol       Date:  2016-09-24       Impact factor: 5.469

7.  Escherichia coli promoters with UP elements of different strengths: modular structure of bacterial promoters.

Authors:  W Ross; S E Aiyar; J Salomon; R L Gourse
Journal:  J Bacteriol       Date:  1998-10       Impact factor: 3.490

8.  Sequence-dependent upstream DNA-RNA polymerase interactions in the open complex with lambdaPR and lambdaPRM promoters and implications for the mechanism of promoter interference.

Authors:  Laura Mangiarotti; Sara Cellai; Wilma Ross; Carlos Bustamante; Claudio Rivetti
Journal:  J Mol Biol       Date:  2008-11-24       Impact factor: 5.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.